AMIT Technion
Digital Health Speech Technologies

Business Overview

Alfred E. Mann established the Alfred Mann Institute for Biomedical Development at Technion-Israel Institute of Technology AMIT is, focused on enabling commercialization of innovative biomedical technologies that improve human health.

Investor type
University
Business model preference
B2B, B2B2C, B2C, B2G
Series preference
Seed, Series A
Offering preference
Software
AI type preference
Artificial Intelligence, Natural Language Processing, Speech Recognition
Sectors
Digital Health Speech Technologies

Investment Portfolio

Startup

Operating Status

Offering Type

Business Model

Total Funding

AI Employees

Voiceitt
Active
Software
B2B, B2B2C, B2C, B2G
$15.8 M
6

Investment Rounds History

Startup

Date Announced

Funding Round

Amount Raised

Investors

Similar Investors

TYPE
Angel
Israel Innovation Authority
TYPE
Government
TYPE
Angel
Titanium Investments
TYPE
Venture Capital
Claltech
TYPE
Corporate Venture Capital
Gemini Israel Ventures
TYPE
Venture Capital
AXA Venture Partners
TYPE
Corporate Venture Capital
MIN CHEQUE
$1 M
iAngels
TYPE
Crowdfunding
MIN CHEQUE
$0.25 M
Amiti Ventures
TYPE
Venture Capital
Singtel Innov8
TYPE
Corporate Venture Capital
Hetz Ventures
TYPE
Venture Capital
Canaan Partners Israel
TYPE
Venture Capital
Incubit Technology Ventures
TYPE
Corporate Venture Capital
FinTLV Ventures
TYPE
Venture Capital
Flint Capital
TYPE
Venture Capital
New Enterprise Associates
TYPE
Venture Capital
NFX Guild
TYPE
Venture Capital
MIN CHEQUE
$1 M
Hyundai
TYPE
Company
SeedIL Ventures
TYPE
Venture Capital
Khosla
TYPE
Venture Capital

Sign up for free

  • Save profiles to your list
  • View all funding rounds
  • Advanced sorting filter access
  • Search investment rounds
  • Search exit events